The Peripheral Neuropathy Treatment Market was valued at USD 4.5 billion in 2024 and is projected to reach USD 9.2 billion by 2034, registering a CAGR of 7.5%. This growth is underpinned by a combination of rising prevalence of peripheral neuropathy, increasing awareness and diagnosis, and advancements in treatment options. Peripheral neuropathy, characterized by damage to the peripheral...